Determinants of interindividual variation of renin and prorenin concentrations: Evidence for a sexual dimorphism of (pro)renin levels in humans

Journal of Hypertension

Volumn 16, Issue 6, 1998, Pages 853-862

  Jan Danser, A H ^a,f   Derkx, Frans H M ^b   Schalekamp, Maarten A D H ^b   Hense, Hans Werner ^c,d   Riegger, Günter A J ^e   Schunkert, Heribert ^e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b University of Münster ^*  (Netherlands)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e UNIVERSITY OF REGENSBURG   (Germany)

^f ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Angiotensin converting enzyme inhibitor; Diabetes; Diuretic; Prorenin; Renin; Sexual dimorphism; adrenergic antagonist

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PRORENIN; RENIN; SEX HORMONE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; DIABETES MELLITUS; ESTROGEN THERAPY; FEMALE; GENE CONTROL; HEART INFARCTION; HUMAN; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 15144347939     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816060-00017     Document Type: Article

References (38)

1. Keeton TK, Campbell WB. The pharmacological alteration of renin release. Pharmacol Rev 1981; 31:81-227.
2. Fritz LC, Haidar MA, Arfsten AE, Schilling JW, Carilli C, Shine J, et al. Human renin is correctly processed and targeted to the regulated secretory pathway in mouse pituitary AtT-20 cells. J Biol Chem 1987; 262:12409-12412.
3. Pratt RE, Flynn JA, Hobart PM, Paul M, Dzau VJ. Different secretory pathways of renin from mouse cells transfected with the human renin gene. J Biol Chem 1987; 263:3137-3141.
4. Toffelmire EB, Slater K, Corvol P, Menard J, Schambelan M. Response of plasma prorenin and active renin to chronic and acute alterations of renin secretion in normal humans. Studies using a direct immunoradiometric assay. J Clin Invest 1989; 83:679-687.
5. Barrett GL, Morgan TO, Smith M, Alcorn D, Aldred P. Effect of converting enzyme inhibition on renin synthesis and secretion in mice. Hypertension 1989; 14:385-395.
6. Kurtz A, Scholz H, della Bruna R. Molecular mechanisms of renin release. J Cardiovasc Pharmacol 1990; 16 (suppl 4):S1-S7.
7. Berka JLA, Alcorn D, Ryan GB, Skinner SL. Renin processing studied by immunogold localization of prorenin and renin in granular juxtaglomerular cells in mice treated with enalapril. Cell Tissue Res 1992; 268: 141-148.
8. Hsueh WA, Baxter JD. Human prorenin. Hypertension 1991; 17: 469-479.
9. Sealey JE, Atlas SA, Laragh JH. Prorenin and other large molecular weight forms of renin. Endocr Rev 1980; 1:365-391.
10. Atlas SA, Sealey JE, Laragh JH, Moon C. Plasma renin and 'prorenin' in essential hypertension during sodium depletion, beta-blockade, and reduced arterial pressure. Lancet 1977; ii:785-789.
11. Derkx FHM, van Gool JMG, Wenting GJ, Verhoeven RP. Man in 't Veld AJ, Schalekamp MADH. Inactive renin in human plasma. Lancet 1976; ii:496-499.
12. Derkx FHM, Schalekamp MADH. Human prorenin: pathophysiology and clinical implications. Clin Exp Hypertens [A] 1988; 10:1213-1225.
13. Hsueh WA, Luetscher JA, Carlson EJ, Grislis G, Fraze E, McHargue A. Changes in active and inactive renin throughout pregnancy. J Clin Endocrinol Metab 1982; 54:1010-1016.
14. Sealey JE, Atlas SA, Glorioso N, Manapat H, Laragh JH. Cyclical secretion of prorenin during the menstrual cycle: synchronization with luteinizing hormone and progesterone. Proc Natl Acad Sci USA 1985; 82:8705-8709.
15. Itskovitz J, Sealey JE, Glorioso N, Rosenwaks Z. Plasma prorenin response to human chorionic gonadotrophin in ovarian-hyperstimulated women: correlation with the number of ovarian follicles and steroid hormone concentrations. Proc Natl Acad Sci USA 1987; 84: 7285-7289.
16. Luetscher JA, Kraemer FB, Wilson DM, Schwartz HC, Bryer-Ash M. Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications. N Engl J Med 1985; 312:1412-1417.
17. Franken AAM, Derkx FHM, Man in 't Veld AJ, Hop WCJ, van Rens GH, Peperkamp E, et al. High plasma prorenin in diabetes mellitus and its correlation with some complications. J Clin Endocrinol Metab 1990; 71:1008-1015.
18. Sealey JE, Atlas SA, Laragh JH. Prorenin in plasma and kidney. Fed Proc 1983; 42:2681-2689.
19. Sealey JE, James GJ, Laragh JH. Interpretation and guidelines for the use of plasma and urine aldosterone and plasma angiotensin II, angiotensinogen, prorenin, peripheral, and renal vein renin tests. In: Laragh JH, Brenner BM (editors). Hypertension: pathophysiology, diagnosis, and management. (Second edition). New York: Raven Press: 1995, pp. 1953-1968.
20. Johannessen A, Nielsen AH, Poulsen K. Sexual dimorphism of inactive renin in rat plasma. Clin Exp Hypertens [A] 1990; 12:1405-1417.
21. Nielsen AH, Johannessen A, Poulsen K. Inactive plasma renin exhibits sex difference in mice. Clin Sci 1989; 76:439-446.
22. Plouin PF, Chatellier G, Guyenne TT, Vincent N, Corvol P. Recent advances in the clinical study of the renin-angiotensin system. Reference values and conditions of validity. Presse Méd 1989; 18:917-921
23. Keil U, Stieber J, Döring A, Härtel U, Filipatrick B, Hense H-W. The cardiovascular risk profile in the study area Augsburg: results from the first MONICA survey 1984/85. Acta Med Scand 1988; 728 (suppl): 119-128.
24. Derkx FHM, de Bruin RJA, van Gool JMG, van den Hoek M-J, Beerendonck CCM, Rosmalen F, et al. Clinical validation of renin monoclonal antibody-based sandwich assays of renin and prorenin, and use of renin inhibitor to enhance prorenin immunoreactivity. Clin Chem 1996; 42:1051-1063.
25. Schunkert H, Ingelfinger JR, Hirsch AT, Tang SS, Litwin SE, Talsness CE, et al. Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure. J Clin Invest 1992; 90:1523-1529.
26. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein C, Lorell BH. Increased rat cardiac angiotensin converting enzyme activity and mRNA levels in pressure overload left ventricular hypertrophy: effects on coronary resistance, contractility and relaxation. J Clin Invest 1990; 86:1913-1920.
27. Schunkert H, Danser AHJ, Hense H-W, Derkx FHM, Kúrzinger S, Riegger GAJ. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 1997; 95:39-45.
28. Mukhopadhyay AK, Cobilanschi J, Schulze W, Brunswick-Spickenheier B, Leidenberger FA. Human seminal fluid contains significant quantities of prorenin: its correlation with sperm density. Mol Cell Endocrinol 1995; 109:219-224.
29. Chen Y-F, Naftilan AJ, Oparil S. Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension 1992; 19:456-463.
30. Wagner D, Metzger R, Paul M, Ludwig G, Suzuki F, Takahashi S, et al. Androgen dependence and tissue specificity of renin messenger RNA expression in mice. J Hypertens 1990; 8:45-52.
31. Bachman J, Feldmer M, Ganten U, Stock G, Ganten D. Sexual dimorphism of blood pressure: possible role of the renin-angiotensin system. J Steroid Biochem Mol Biol 1991; 40:4-6.
32. Alderman MH, Sealey JE, Laragh JH. Plasma renin activity and ischemic heart disease [letter]. W Engl J Med 1994; 330:506-507.
33. Sealey JE, Rubattu S. Prorenin and renin as separate mediators of tissue and circulating systems. Am J Hypertens 1989; 2:358-366.
34. Sealey JE, Catanzaro DF, Pitarresi TM, Gahnem F, Hu L-F, Lavin T, et al. Antihypertensive effect of prorenin in conscious rats with Ang II induced hypertension and demonstration of prorenin binding [abstract]. J Hypertens 1996, 14 (suppl 1):S290.
35. Wilson DM, Stevenson DK, Luetscher JA. Plasma prorenin and renin in childhood and adolescence. Am J Dis Child 1988; 142:1070-1072.
36. Trenkwalder P, James GD, Laragh JH, Sealey JE. Plasma renin activity and plasma prorenin are not suppressed in hypertensives surviving to old age. Am J Hypertens 1996; 9:621-627.
37. Henrich WL, McAllister EA, Smith PB, Campbell WB. Guanosme 3′,5′-cyclic monophosphate as a mediator of inhibition of renin release. Am J Physiol 1988; 255:F474-F478.
38. McMurray JJ, Struthers AD. Atrial natriuretic factor inhibits isoproterenol- and furosemide-stimulated renin release in humans. Hypertension 1989; 13:9-14.